As far as we are aware, no previous study has demonstrated a significant correlation of T790M mutation between tumor samples and plasma cfDNA in individuals with EGFR-mutant NSCLC that has acquired resistance to EGFR-TKIs. The gene discussed is EGFR; the disease is neoplasm.